A-blockers for the management of lower urinary tract symptoms in patients with prostate cancer treated with external beam radiotherapy: a randomized controlled study.
Kimon TsirkasAnna ZygogianniAndromachi KougioumtzopoulouVasileios KoulouliasZoi LiakouliAthanasios PapatsorisJohn GeorgakopoulosChristos AntypasChristina ArmpilliaAthanasios DellisPublished in: World journal of urology (2020)
The selective use of α-blocker appears to prevent AUR in EBRT-treated patients. Although the administration of α-blockers might relieve patient-reported symptoms, there are no established independent predictive factors to distinguish patients who may benefit.
Keyphrases
- patient reported
- prostate cancer
- lower urinary tract symptoms
- newly diagnosed
- angiotensin converting enzyme
- end stage renal disease
- benign prostatic hyperplasia
- ejection fraction
- chronic kidney disease
- early stage
- radical prostatectomy
- prognostic factors
- peritoneal dialysis
- radiation therapy
- radiation induced
- depressive symptoms
- monte carlo